Keyword Connections

hospital-acquired pneumonia

Journals

5

1 Antimicrobial agents and chemotherapy

2 The Journal of antimicrobial chemotherapy

3 The Review of scientific instruments

4 Boletin de la Asociacion Medica de Puerto Rico

5 Medicina espanola

Research Groups

0

No Research Group Connected

Bibliographies

19

1 Individual meropenem epithelial lining fluid and plasma PK/PD target attainment.

2 Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.

3 Note: Effective anvil size for transverse delamination test of rare-earth-Ba₂Cu₃Oy coated conductor tapes.

4 Note: Effective measurement of retained I(c) in evaluating electromechanical properties of high temperature superconductor tapes by the voltage tap clipping technique.

5 Experimental measurement of characteristic I(c) (ε, θ, B) response in GdBa2Cu3Oδ coated conductor tapes under low magnetic field at 77 K.

6 Our tribute to the memory of Professor Gascó Pascual; dedication.

7 Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in Guang Zhou

8 Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

9 Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in Guang Zhou

10 Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

11 Implementation of French Recommendations for the Prevention and the Treatment of Hospital-acquired Pneumonia: A Cluster-randomized Trial

12 Hospital-Acquired Pneumonia, Health Care-Associated Pneumonia, Ventilator-Associated Pneumonia, and Ventilator-Associated Tracheobronchitis: Definitions and Challenges in Trial Design

13 Recommendations for Improving the Design, Conduct, and Analysis of Clinical Trials in Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

14 Review of Recent Clinical Trials of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Perspective from Academia

15 Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator-Associated Pneumonia and Hospital-Acquired Pneumonia

16 End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration Perspective

17 Considerations Unique to Pediatrics for Clinical Trial Design in Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

18 Challenges in the Design and Conduct of Clinical Trials for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: An Industry Perspective

19 Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia